微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.35% | -29.73% | 53.44% | 9/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 4.79% | -30.58% | 73.55% | 8/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 2.76% | -4.83% | -77.56% | 8/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 12.3% | -41.84% | 17.59% | 11/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 10.46% | -50.98% | 51.59% | 11/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 6.9% | -47.61% | 137.93% | 11/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 2.9% | 194.16% | -86.29% | 14/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 21.15% | -27.47% | -0.89% | 8/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 21.34% | 26.65% | 62.03% | 8/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 13.17% | -10.83% | -54.84% | 7/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2021-12-31 | 29.16% | 19.17% | 97.43% | 3/51 | -6.68% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-06-30 | 14.77% | 2% | -39.64% | 6/51 | 2.28% | 澳洋健康 | 40.93% | 行业排名> |
| 2020-12-31 | 24.47% | 34.38% | 45.22% | 11/51 | 10.95% | 金域医学 | 43.58% | 行业排名> |
| 2020-09-30 | 16.85% | 2% | 647.08% | 9/51 | 7.83% | 金域医学 | 35.41% | 行业排名> |
| 2020-03-31 | -3.08% | 2% | -116.91% | 27/51 | -0.22% | 阳光诺和 | 26.2% | 行业排名> |
| 2019-12-31 | 18.21% | -9.54% | -9.54% | 15/51 | 65.31% | 金域医学 | 13.23% | 行业排名> |
| 2018-12-31 | 20.13% | 71.17% | 71.17% | 9/51 | -0.6% | 万邦医药 | 52.05% | 行业排名> |
| 2017-12-31 | 11.76% | 2% | 2% | 15/51 | 1.73% | 华大基因 | 48.52% | 行业排名> |